West Pharmaceutical Services reported a 40 per cent increase in
operating profit for the first quarter of 2007, despite profits
diving 43 per cent in the Tech Group business that makes the
delivery device for Pfizer's inhaled...
While Lonza's biopharmaceutical business has taken off, tough
competition from cheap Asian competitors is eating away at its
exclusive synthesis business - meanwhile, the whole business is
being hit by rising raw material and...
West Pharmaceutical Services has reported a huge surge in both
sales and profits for its second quarter, spurred on by the
increasing demand for injectable drugs as well as the lucrative
Exubera manufacturing contract, which helped...
Pliva, Eastern Europe's biggest drug maker by sales, saw its
profits take a massive dive in the first quarter of 2006, as a huge
loss of royalties could not be offset by the relatively small
growth in its generics business.
PPD managed a 42 per cent jump in pre-tax profit to the tune of
$63.8m (€50.1m) in the first quarter, fuelled by a strong growth in
new clinical trials business and helped by a milestone payment in
the discovery sciences segment.
Italian packaging and processing machinery company IMA Group has
posted a net profit of €13m for 2005, down 24 per cent from 2004,
since a rise in revenues was offset by one-off charges, operating
costs and a reduction in prices as...
Rising prices globally have helped Dutch chemicals manufacturer DSM
go back to profit in Q4, up to €112m (€134m) from €3m in the red a
year ago, with operating profits in its Life Science division
almost doubling to €39m, albeit thanks...
DSM announced that higher margins and lower fixed costs had boosted
operating profits by 44 per cent to €220 million in the third
quarter, with the performance materials and industrial chemicals
divisions leading the increase.
Dutch group DSM, one of Europe's top three ingredient suppliers to
drug makers, increased sales of pharma products during the second
quarter but continued losses from the antibiotics market halved the
Life Sciences operating...
Swiss life sciences supplier Tecan has reported flat growth in
sales but higher profits in the first quarter of 2004, which it
said was largely the result of the restructuring measures
implemented in 2003.